Inventor
CAI JIANFENG
US36 patents
⚠️ This page may combine multiple inventors who share the name “CAI JIANFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV SOUTH FLORIDA
15 patentsUS10738082B2Aug 11, 2020
One-bead-two-compound macrocyclic library and methods of preparation and use
UNIV SOUTH FLORIDA2 citations73
US11214550B2Jan 4, 2022
Bis-cyclic guanidines as antibacterial agents
UNIV SOUTH FLORIDA1 citations69
US10144713B1Dec 4, 2018
Bis-cyclic guanidines as antibacterial agents
UNIV SOUTH FLORIDA2 citations69
US12145969B2Nov 19, 2024
Compositions and methods relating to novel sulfono-gamma-AA peptides
UNIV SOUTH FLORIDA0 citations62
US11254704B2Feb 22, 2022
Compounds and methods for reducing or inhibiting aggregation of proteins in a subject
UNIV SOUTH FLORIDA0 citations62
US11149065B2Oct 19, 2021
One-bead-two-compound macrocyclic library and methods of preparation and use
UNIV SOUTH FLORIDA1 citations62
US10836793B2Nov 17, 2020
Compounds for the treatment of neurodegenerative diseases
UNIV SOUTH FLORIDA1 citations62
US12486537B2Dec 2, 2025
Methods and compositions for diagnosis and management of neurodegenerative diseases
UNIV SOUTH FLORIDA0 citations61
US11278521B2Mar 22, 2022
GAS5 binding compounds, formulations, and uses thereof
UNIV SOUTH FLORIDA1 citations61
US11718585B2Aug 8, 2023
Bis-cyclic guanidines as antibacterial agents
UNIV SOUTH FLORIDA0 citations59
US11078164B1Aug 3, 2021
PTEN binding compounds, formulations, and uses thereof
UNIV SOUTH FLORIDA0 citations55
US12162874B2Dec 10, 2024
Peptidomimetic-based antibody surrogate for HER2
UNIV SOUTH FLORIDA0 citations53
US11866474B2Jan 9, 2024
Modulating angiogenesis by proteomimetics of vascular endothelial growth factor
UNIV SOUTH FLORIDA0 citations53
US12415832B2Sep 16, 2025
B-catenin/B-cell Lymphoma 9 protein-protein interaction inhibiting peptidomimetics
UNIV SOUTH FLORIDA0 citations48
US10022420B2Jul 17, 2018
Methods of synthesizing γ-AApeptides, γ-AApeptide building blocks, γ-AApeptide libraries, and γ-AApeptide inhibitors of Aβ40 aggregates
UNIV SOUTH FLORIDA0 citations48
CAI JIANFENG
8 patentsUS9645155B2May 9, 2017
Methods of synthesizing γ-aapeptides, γ-aapeptide building blocks, γ-aapeptide libraries, and γ-aapeptide inhibitors of Aβ40 aggregates
CAI JIANFENG4 citations68
US10308686B2Jun 4, 2019
Gamma-AApeptides with potent and broad-spectrum antimicrobial activity
CAI JIANFENG1 citations57
US9499587B2Nov 22, 2016
Gamma-AApeptides with potent and broad-spectrum antimicrobial activity
CAI JIANFENG1 citations57
US10538553B2Jan 21, 2020
Compounds for the treatment of neurodegenerative diseases
CAI JIANFENG0 citations50
US9234007B2Jan 12, 2016
RGD mimetic γ-AApeptides and methods of use
CAI JIANFENG1 citations48
US10144764B2Dec 4, 2018
γ-AApeptides with potent and broad-spectrum antimicrobial activity
CAI JIANFENG1 citations46
US10793526B2Oct 6, 2020
Hydantoin derivative compounds, methods of use and methods of treatment
CAI JIANFENG0 citations45
US10457646B1Oct 29, 2019
Hydantoin derivative compounds, methods of use and methods of treatment
CAI JIANFENG0 citations45
MICROSOFT TECHNOLOGY LICENSING LLC
6 patentsUS10289403B1May 14, 2019
Enhanced server farm patching system for enabling developers to override off-peak patching schedules
MICROSOFT TECHNOLOGY LICENSING LLC21 citations90
US10374930B2Aug 6, 2019
Off-peak patching for enterprise stability
MICROSOFT TECHNOLOGY LICENSING LLC6 citations65
US11256607B1Feb 22, 2022
Adaptive resource management for instantly provisioning test environments via a sandbox service
MICROSOFT TECHNOLOGY LICENSING LLC2 citations64
US10996941B2May 4, 2021
Enabling tenant administrators to initiate request driven peak-hour builds to override off-peak patching schedules
MICROSOFT TECHNOLOGY LICENSING LLC1 citations57
US10678533B2Jun 9, 2020
Enhanced server farm patching system for enabling developers to override off-peak patching schedules
MICROSOFT TECHNOLOGY LICENSING LLC0 citations48
US10585659B2Mar 10, 2020
Enabling tenant administrators to initiate request driven peak-hour builds to override off-peak patching schedules
MICROSOFT TECHNOLOGY LICENSING LLC0 citations46
H LEE MOFFITT CANCER CT & RES
3 patentsUS10507228B2Dec 17, 2019
Methods and compositions related to KRAS inhibitors
H LEE MOFFITT CANCER CT & RES0 citations52
US10351596B2Jul 16, 2019
γ-AA-peptide STAT3/DNA inhibitors and methods of use
H LEE MOFFITT CANCER CT & RES0 citations52
US10000531B2Jun 19, 2018
Gamma-AA-peptide STAT3/DNA inhibitors and methods of use
H LEE MOFFITT CANCER CT & RES0 citations52